Related Experiment Videos

[Complement level in serum from patients with chronic hepatitis]

Bilten Za Hematologiju I Transfuziju
|January 1, 1981
PubMed

Insights

Complement levels in hepatitis patients correlate with disease severity and liver function markers, not HBsAg presence. Immune complexes may affect HBsAg detection.

Area of Science:

  • Immunology
  • Hepatology
  • Biochemistry

Context:

  • Investigated complement system activation in patients with chronic active hepatitis and chronic persistent hepatitis.
  • Assessed various complement components (CH50, C1q, C1s, C4, C3, C5, C9, C1 Inh, C3a) in patient serum.
  • Examined the relationship between complement levels and hepatitis B surface antigen (HBsAg) presence.

Purpose:

  • To determine complement component levels in hepatitis patients.
  • To explore correlations between complement activation and clinical/biochemical parameters.
  • To investigate the influence of immune complexes on HBsAg detection.

Summary:

  • Complement (C) levels in hepatitis patients are linked to bilirubin, transaminases, and immunoglobulin levels, reflecting disease severity.
  • Complement changes were independent of hepatitis B surface antigen (HBsAg) presence in serum.
  • Elevated C1 inhibitor (C1 Inh) correlated with complement activation intensity, and dissociated C1q/C1s levels suggested immune complexes potentially interfering with HBsAg detection.

Impact:

  • Provides insights into the role of the complement system in hepatitis pathogenesis.
  • Highlights the relationship between complement activation and liver injury markers.
  • Suggests potential mechanisms for altered HBsAg detection in hepatitis patients.

Related Concept Videos